Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
MariMed Inc (MRMD)
OTHER OTC:MRMD
MariMed (MRMD) Stock Price & Analysis
405 Followers
MRMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.20 - $0.55
Previous Close$0.27
Volume65.35K
Average Volume (3M)501.15K
Market Cap
$99.77M
Enterprise Value$119.02M
Total Cash (Recent Filing)$13.42M
Total Debt (Recent Filing)$36.56M
Price to Earnings (P/E)-6.3
Beta0.81
Next Earnings
May 08, 2024EPS Estimate
-$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding375,129,966
10 Day Avg. Volume297,985
30 Day Avg. Volume501,155
Standard Deviation0.39
R-Squared0.15
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.89
Price to Sales (P/S)2.84
Price to Cash Flow (P/CF)3.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.82
Enterprise Value/Gross Profit1.86
Enterprise Value/Ebitda5.15
Forecast
1Y Price Target
$0.36Price Target Upside29.87% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
MariMed News
PremiumPress Releases
MariMed Partners with Iconic Boston Music Venues
Bulls Say, Bears Say
Bulls Say
Financial RestructuringMariMed’s recent debt refinancing alleviates immediate cash flow pressures, enabling the company to strategically allocate funds towards capital expenditure projects.
Growth PotentialMariMed's growth trajectory is supported by the addition of new stores, expansion of cultivation capacity, and the anticipated launch of adult-use cannabis sales in new markets.
Valuation And PerformanceAnalysts highlight MariMed's compelling valuation, trading at lower multiples compared to peers, combined with a strong track record in its wholesale segment and the prospect of generating positive free cash flow in the near future.
Bears Say
Financial PerformanceMariMed Inc. reported Q4 results that were below expectations with sales and adjusted EBITDA falling well below both analyst expectations and management’s revised guidance.
Future GuidanceMariMed Inc. projected a conservative outlook for 2024, with revenue and adjusted EBITDA growth forecasts not meeting the consensus estimates, indicating potential challenges ahead.
Operating CostsIncreased operating costs, stemming from construction delays, higher-than-expected staffing costs, and other start-up expenses, significantly impacted MariMed Inc.'s recent financial performance.
---
Ownership Overview
28.15% Insiders
0.00% Mutual Funds
0.13% Other Institutional Investors
71.73% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
MRMD FAQ
What was MariMed Inc’s price range in the past 12 months?
MariMed Inc lowest stock price was $0.20 and its highest was $0.55 in the past 12 months.
What is MariMed Inc’s market cap?
Currently, no data Available
When is MariMed Inc’s upcoming earnings report date?
MariMed Inc’s upcoming earnings report date is May 08, 2024 which is in 14 days.
How were MariMed Inc’s earnings last quarter?
MariMed Inc released its earnings results on Mar 06, 2024. The company reported $0.001 earnings per share for the quarter, beating the consensus estimate of $0 by $0.001.
Is MariMed Inc overvalued?
According to Wall Street analysts MariMed Inc’s price is currently Undervalued.
Does MariMed Inc pay dividends?
MariMed Inc does not currently pay dividends.
What is MariMed Inc’s EPS estimate?
MariMed Inc’s EPS estimate is -$0.01.
How many shares outstanding does MariMed Inc have?
MariMed Inc has 375,129,970 shares outstanding.
What happened to MariMed Inc’s price movement after its last earnings report?
MariMed Inc reported an EPS of $0.001 in its last earnings report, beating expectations of $0. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of MariMed Inc?
Currently, no hedge funds are holding shares in MRMD
---
MariMed Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.36 (29.87% Upside)
$0.36 (29.87% Upside)
Blogger Sentiment
Bullish
MRMD Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Positive
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 3.3%
Last 30 Days ▲ 3.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.68%
12-Months-Change
Fundamentals
Return on Equity
-19.07%
Trailing 12-Months
Asset Growth
28.86%
Trailing 12-Months
Company Description
MariMed Inc
MariMed, Inc. engages in direct owning of cannabis licenses and management of seed-to-sale operations. The company develops precision-dosed cannabis-infused products designed for specific medical conditions and related symptoms. Its products are licensed under brands of Kalm Fusion, Betty's Eddies, and Nature's Heritage, in the form of dissolvable strips, tablets, powders, microwaveable popcorn, and fruit chews. The company was founded by Robert N. Fireman and Jon Levine on January 25, 2011 and is headquartered in Norwood, MA.
---
MRMD Earnings Call
Q4 2024
0:00 / 0:00
---
MRMD Stock 12 Months Forecast
Average Price Target
$0.36
▲(29.87% Upside)
Technical Analysis
Best Analysts Covering MRMD
1 Year
1 Year Success Rate
1/12 ratings generated profit
1 Year Average Return
-26.72%
reiterated a buy rating 2 months ago
Copying Andrew Semple's trades and holding each position for 1 Year would result in 8.33% of your transactions generating a profit, with an average return of -26.72% per trade.
---